• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用柠檬酸去除 HLA Ⅰ类分子和辐照机采血小板输注难治患者。

HLA class I depletion by citric acid, and irradiation of apheresis platelets for transfusion of refractory patients.

机构信息

Department of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway.

Department of Hematology, Oslo University Hospital, Oslo, Norway.

出版信息

Transfusion. 2021 Apr;61(4):1222-1234. doi: 10.1111/trf.16282. Epub 2021 Feb 13.

DOI:10.1111/trf.16282
PMID:33580979
Abstract

BACKGROUND

Patients can form antibodies to foreign human leukocyte antigen (HLA) Class I antigens after exposure to allogeneic cells. These anti-HLA class I antibodies can bind transfused platelets (PLTs) and mediate their destruction, thus leading to PLT refractoriness. Patients with PLT refractoriness need HLA-matched PLTs, which require expensive HLA typing of donors, antibody analyses of patient sera and/or crossmatching. An alternative approach is to reduce PLT HLA Class I expression using a brief incubation in citric acid on ice at low pH.

METHODS AND MATERIALS

Apheresis PLT concentrates were depleted of HLA Class I complexes by 5 minutes incubation in ice-cold citric acid, at pH 3.0. Surface expression of HLA Class I complexes, CD62P, CD63, phosphatidylserine, and complement factor C3c was analyzed by flow cytometry. PLT functionality was tested by thromboelastography (TEG).

RESULTS

Acid treatment reduced the expression of HLA Class I complexes by 71% and potential for C3c binding by 11.5-fold compared to untreated PLTs. Acid-treated PLTs were significantly more activated than untreated PLTs, but irrespective of this increase in steady-state activation, CD62P and CD63 were strongly upregulated on both acid-treated and untreated PLTs after stimulation with thrombin receptor agonist peptide. Acid treatment did not induce apoptosis over time. X-ray irradiation did not significantly influence the expression of HLA Class I complexes, CD62P, CD63, and TEG variables on acid treated PLTs.

CONCLUSION

The relatively simple acid stripping method can be used with irradiated apheresis PLTs and may prevent transfusion-associated HLA sensitization and overcome PLT refractoriness.

摘要

背景

患者在接触同种异体细胞后会产生针对异源性人白细胞抗原(HLA)I 类抗原的抗体。这些抗 HLA I 类抗体可与输注的血小板(PLT)结合并介导其破坏,从而导致 PLT 反应性降低。PLT 反应性降低的患者需要 HLA 匹配的 PLT,这需要对供体进行昂贵的 HLA 分型、患者血清的抗体分析和/或交叉配型。替代方法是通过在冰上用柠檬酸短暂孵育来降低 PLT HLA I 类表达,使其处于低 pH 值。

方法和材料

通过在冰冷的柠檬酸中孵育 5 分钟,使富含血小板的分离物 PLT 耗尽 HLA I 类复合物,pH 值为 3.0。通过流式细胞术分析 HLA I 类复合物、CD62P、CD63、磷脂酰丝氨酸和补体因子 C3c 的表面表达。通过血栓弹性描记术(TEG)测试 PLT 功能。

结果

与未处理的 PLT 相比,酸处理使 HLA I 类复合物的表达减少了 71%,潜在的 C3c 结合减少了 11.5 倍。酸处理后的 PLT 比未处理的 PLT 明显更活跃,但无论这种稳态激活增加多少,在用凝血酶受体激动肽刺激后,酸处理和未处理的 PLT 上的 CD62P 和 CD63 都被强烈上调。随着时间的推移,酸处理不会诱导细胞凋亡。X 射线照射不会显著影响 HLA I 类复合物、CD62P、CD63 和 TEG 变量在酸处理后的 PLT 上的表达。

结论

相对简单的酸剥离方法可用于辐照后的富含血小板的分离物,可预防与输血相关的 HLA 致敏并克服 PLT 反应性降低。

相似文献

1
HLA class I depletion by citric acid, and irradiation of apheresis platelets for transfusion of refractory patients.用柠檬酸去除 HLA Ⅰ类分子和辐照机采血小板输注难治患者。
Transfusion. 2021 Apr;61(4):1222-1234. doi: 10.1111/trf.16282. Epub 2021 Feb 13.
2
Effects of storage on quality and function of acid-treated platelets with reduced HLA Class I surface expression.储存对 HLA I 类表面表达降低的酸处理血小板的质量和功能的影响。
Transfus Med. 2023 Aug;33(4):329-336. doi: 10.1111/tme.12983. Epub 2023 Jun 25.
3
Proteomic study of apheresis platelets made HLA class I deficient for transfusion of refractory patients.免疫吸附血小板去除 HLA I 类抗原的蛋白质组学研究及其在难治性患者输血中的应用
Proteomics Clin Appl. 2021 Nov;15(6):e2100022. doi: 10.1002/prca.202100022. Epub 2021 Sep 22.
4
Recovery, survival, and function of transfused platelets and detection of platelet engraftment after allogeneic stem cell transplantation.输注血小板的恢复、存活和功能以及异基因干细胞移植后血小板植入的检测。
Transfusion. 2012 Jun;52(6):1321-32. doi: 10.1111/j.1537-2995.2011.03442.x. Epub 2011 Nov 16.
5
Platelets made HLA deficient by acid treatment aggregate normally and escape destruction by complement and phagocytes in the presence of HLA antibodies.经酸处理而缺乏HLA的血小板能正常聚集,并且在存在HLA抗体的情况下可逃避补体和吞噬细胞的破坏。
Transfusion. 2016 Feb;56(2):370-82; quiz 369. doi: 10.1111/trf.13350. Epub 2015 Oct 7.
6
Response to random apheresis platelets versus HLA-selected platelets versus pooled platelets in HLA-sensitized patients.随机单采血小板与 HLA 配型血小板及混合血小板在 HLA 致敏患者中的反应。
Transfusion. 2019 Jul;59(7):2276-2281. doi: 10.1111/trf.15333. Epub 2019 Apr 29.
7
Genetically engineered blood pharming: generation of HLA-universal platelets derived from CD34+ progenitor cells.基因工程血液制药:源自CD34+祖细胞的HLA通用血小板的生成
J Stem Cells. 2014;9(3):149-61.
8
HLA-universal platelet transfusions prevent platelet refractoriness in a mouse model.HLA通用型血小板输注可预防小鼠模型中的血小板输注无效。
Hum Gene Ther. 2013 Dec;24(12):1018-28. doi: 10.1089/hum.2013.074. Epub 2013 Nov 7.
9
Efficacy of HLA virtual cross-matched platelet transfusions for platelet transfusion refractoriness in hematopoietic stem cell transplantation.HLA 虚拟交叉配型血小板输注治疗造血干细胞移植后血小板输注无效的疗效。
Transfusion. 2020 Mar;60(3):473-478. doi: 10.1111/trf.15664. Epub 2020 Jan 22.
10
Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation.人类白细胞抗原 I 类抗体与肝移植患者血小板输注反应。
J Surg Res. 2020 Nov;255:99-105. doi: 10.1016/j.jss.2020.05.029. Epub 2020 Jun 16.

引用本文的文献

1
Anti-HLA Class I alloantibodies in platelet transfusion refractoriness: From mechanisms and determinants to therapeutic prospects.血小板输注无效中的抗 HLA Ⅰ类同种抗体:从机制和决定因素到治疗前景。
Front Immunol. 2023 Feb 9;14:1125367. doi: 10.3389/fimmu.2023.1125367. eCollection 2023.
2
Evidence-Based Minireview: Strategies to manage a severely HLA-alloimmunized patient with refractory thrombocytopenia.循证医学小型综述:管理一名患有难治性血小板减少症的严重HLA同种免疫患者的策略
Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):437-441. doi: 10.1182/hematology.2022000416.
3
Evaluation and management of platelet transfusion refractoriness.
血小板输注无效的评估与处理
Blood Res. 2022 Apr 30;57(S1):6-10. doi: 10.5045/br.2022.2021229.